Sector valuations Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
16:00:00 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| 10-01 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| 10-01 | Monte Rosa Therapeutics, Inc. - Special Call |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | -7.1x | - | -0.03x | - | - | - | - | 896M | |
| 21.73x | 5.12x | 1.32x | 7.71x | 15.48x | 17.22x | 1.37% | 74.16B | |
| 29.82x | 5.88x | 0.52x | 8.57x | 26.7x | 27.19x | 0.04% | 57.39B | |
| 32.98x | 4.47x | 1.22x | 5.93x | 17.77x | 24.83x | 0.98% | 47.64B | |
| -21.31x | 22.39x | -0.34x | 230.81x | -22.97x | -21.83x | -.--% | 44.29B | |
| 33.26x | 6.18x | -34.33x | 3.23x | 13.97x | 20.6x | -.--% | 42.5B | |
| 46.77x | 7.65x | 0.23x | 5.41x | 29.66x | 34.13x | -.--% | 40.71B | |
| 27.63x | 2.23x | 0.57x | 7.93x | 20.48x | 23.94x | 0.41% | 30.97B | |
| 32.99x | 3.46x | 1.51x | 7.05x | 18.3x | 21.94x | -.--% | 28.53B | |
| -15.1x | 1.24x | -0.71x | 5.68x | -7.14x | -5.63x | -.--% | 24.34B | |
| -68.17x | 34.35x | 0.91x | 13.07x | -66.65x | -75.83x | -.--% | 24.27B | |
| 28.11x | 3.35x | -1.62x | 5.3x | 17.62x | 19.88x | -.--% | 20.32B | |
| 34.09x | 25.41x | 2.26x | 5.59x | 25.42x | 26.59x | -.--% | 16.73B | |
| 43.11x | 10.56x | 0.36x | 15.98x | 32.84x | 35.27x | 0.34% | 15.16B | |
| 24.96x | 2.77x | 0.72x | 2.17x | 9.33x | 14.44x | 1.07% | 14.63B | |
| 18.03x | 5.56x | 1.1x | 5.37x | 12.55x | 13.3x | -.--% | 14.47B | |
| 1027.1x | 16.66x | -8.26x | 35.89x | 619.98x | -232.24x | -.--% | 14.38B | |
| 77.11x | 4.62x | -0.34x | 4.09x | 15.7x | 19.48x | -.--% | 13.85B | |
| -55.05x | 27.58x | 42.96x | 9.04x | 220.86x | -1683.23x | -.--% | 13.83B | |
| Average | 69.00x | 10.53x | 0.42x | 21.05x | 55.55x | -95.55x | 0.23% | 28.37B | |
| Weighted average by Cap. | 45.52x | 9.27x | -1.31x | 26.16x | 32.45x | -36.88x | 0.34% |
- Stock Market
- Stocks
- GLUE Stock
- Sector Monte Rosa Therapeutics, Inc.
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
